… Our study demonstrates that loss of Ep-CAM and CD44v6 (VFF18) expression in gastric
cancer has additional prognostic value to the TNM stage. If confirmed, these findings can be …

… In this study, 34% of gastric carcinoma showed Ep-CAM overexpression that related with
histological grade and intestinal type of Lauren classification, but not with tumor progression …

… from a large panel of gastric and prostate cancer samples are … gastric and prostate cancers
as well as adenocarcinoma of the lung are promising indications for treatment with Ep-CAM…

… Taken together, our findings show that E-cadherin and EpCAM exhibit high rates of … in
patients with early gastric cancer. Thus, E-cadherin and EpCAM are potential molecular markers …

… EpCAM was a potential oncogene and contributed to the growth of gastric cancer. Our data
… compelling evidence of potential value of EpCAM in the therapy of gastric cancer in clinic. …

… gastrectomy for adenocarcinomas of the stomach or the oesophago–gastric junction between
… Study inclusion criteria were no evidence of any gastric neoplasia. The mean age of the …

… EpCAM) is one of the most commonly used markers of cancer stem cells (CSCs), but the
clinical and prognostic significance of EpCAM in gastric … Loss of Ep-CAM (CO17-1A) expression …

… High EpCAM expression associates with proliferation and progression of gastric cancer, …
of the current adjuvant concepts for gastric cancer patients, EpCAM might be target in the …

… MKN 28 cells were subjected to infection with AdCMVluc (open bars) or AdCMVluc complexed
to bispecific antibody±conjugate anti-EpCAM/antiknob (black bars) at MOI of 100 particles…

… Ep-CAM expression in primary tumor specimens from primary gastric adenocarcinoma was
… However, loss of Ep-CAM expression is an independent prognostic value for poor survival …